Taken all together, our data suggest that tumour hypoxia promotes CSRP2 overexpression, exacerbating the clinical outcome of breast cancer patients by enhancing tumour cell invasion and subsequent spread to distant tissues. The gene discussed is CSRP2; the disease is neoplasm.